For instance, bradycardia (ROR = 32.65) emerged as the most frequent AE associated with donepezil treatment (22), sinus bradycardia (ROR = 52.95) presented a significantly higher risk value than other cardiac events, indicating a specific influence of cholinesterase inhibition on sinus node function. Here, BCHE is linked to Sinus bradycardia.